The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clopidogrel     Quarter: 2016Q3

Total Drug/Injury Combinations: 736     Number of Pages: 37

DRUGNAME PT EventCount
CLOPIDOGREL Diarrhoea haemorrhagic 1 view events
CLOPIDOGREL Dieulafoy's vascular malformation 1 view events
CLOPIDOGREL Disease progression 1 view events
CLOPIDOGREL Diverticulitis 1 view events
CLOPIDOGREL Drug dose omission 1 view events
CLOPIDOGREL Drug hypersensitivity 1 view events
CLOPIDOGREL Drug prescribing error 1 view events
CLOPIDOGREL Duodenal ulcer haemorrhage 1 view events
CLOPIDOGREL Dysaesthesia 1 view events
CLOPIDOGREL Dysentery 1 view events
CLOPIDOGREL Ear disorder 1 view events
CLOPIDOGREL Ecchymosis 1 view events
CLOPIDOGREL Eczema 1 view events
CLOPIDOGREL Ejection fraction decreased 1 view events
CLOPIDOGREL Electrocardiogram abnormal 1 view events
CLOPIDOGREL Embolic cerebral infarction 1 view events
CLOPIDOGREL End stage renal disease 1 view events
CLOPIDOGREL Eructation 1 view events
CLOPIDOGREL Escherichia urinary tract infection 1 view events
CLOPIDOGREL Extradural haematoma 1 view events

Total Drug/Injury Combinations: 736     Number of Pages: 37

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)